ANYSELaboratory Analytical InstrumentsFiscal year ends October 31
AGILENT TECHNOLOGIES, INC.
Financials through Q3 FY2026, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 1, 2026
$169.90−3.07 (-1.77%)
Close on Oct 19, 2026
- Market cap
- $48.08B
- P/E (TTM)
- 33.5
- Dividend yield
- 0.58%
Margins
Share of revenue, fiscal years 2011 to 2025
Gross margin
52.4%−0.7 pts over 5 years
Operating margin
21.3%+5.4 pts over 5 years
Net margin
18.8%+5.3 pts over 5 years
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +6.7% | +0.5% | +5.4% | +5.6% | |
| Gross profit | +3.1% | -0.7% | +5.1% | +6.0% | |
| Operating income | -0.6% | -2.9% | +11.8% | +11.0% | |
| Net income | +1.1% | +1.3% | +12.6% | – | |
| EPS, diluted | +3.2% | +3.0% | +14.7% | +14.3% | |
| Free cash flow | -16.1% | +4.1% | +7.5% | +10.8% | |
| Dividend per share | +5.1% | +5.7% | +6.6% | +9.5% |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | – | 14.9% | 20.6% | |
| Return on assets | – | 7.5% | 10.6% | |
| Current ratio | 3.85 | 2.33 | 1.96 | |
| Debt to equity | 0.45 | 0.48 | – | |
| Net debt to EBITDA | -0.45× | 0.79× | – | |
| Interest coverage | 8.5× | 10.8× | 13.2× | |
| Inventory turnover | 3.7× | 3.6× | 3.3× | |
| Capex to revenue | 3.3% | 2.2% | 5.9% | |
| Diluted shares | 329M | 312M | 285M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Agilent Technologies generated $7.88B from operations and spent $6.95B on capital expenditure, dividends and share buybacks. 22% of that went back into the business.
Generated
$7.88B
Used
$6.95B
Capital expenditure$1.56B22%Dividends$1.31B19%Share buybacks$4.08B59%
DuPont analysis
Return on equity split into margin, efficiency and leverage
Net margin18.8%
×Asset turnover0.57×
×Equity multiplier1.94×
=Return on equity, FY202520.6%
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | 18.8% | 0.57× | 1.94× | 20.6% |
| FY2024 | 19.8% | 0.58× | 1.93× | 22.0% |
| FY2023 | 18.1% | 0.64× | 1.91× | 22.2% |
| FY2022 | 18.3% | 0.64× | 1.99× | 23.5% |
| FY2021 | 19.1% | 0.62× | 1.98× | 23.6% |
| FY2020 | 13.5% | 0.56× | 1.98× | 14.9% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
4of 8 tests passed in fiscal 2025. Some tests lack the figures they need.
- ProfitableNet income above zero$1.30B
- Cash generatingOperating cash flow above zero$1.56B
- Return on assets improvedROA up on the prior year12.0% → 11.0%
- Earnings backed by cashOperating cash flow above net income$1.56B vs $1.30B
- Less leverageLong-term debt to assets fell– → –
- Better liquidityCurrent ratio rose2.09 → 1.96
- No dilutionShare count did not rise291M → 285M
- Gross margin improvedGross margin up on the prior year54.30% → 52.43%
- More efficientAsset turnover rose0.60 → 0.59